Labat Africa (JSE:LAB) Receivables Turnover: 0.61 (As of Nov. 2025)


What is Labat Africa Receivables Turnover?

Labat Africa JSE:LAB Receivables Turnover is 0.61 as of Nov. 2025. The stock has 5 warning signs investors should review. Among 942 Drug Manufacturers companies, Labat Africa ranks worse than 92.57% on this metric.

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Labat Africa's Revenue for the six months ended in Nov. 2025 was R150.9 Mil. Labat Africa's average Accounts Receivable for the six months ended in Nov. 2025 was R246.1 Mil. Hence, Labat Africa's Receivables Turnover for the six months ended in Nov. 2025 was 0.61.


Labat Africa  (JSE:LAB) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Labat Africa Receivables Turnover Related Terms


Labat Africa Receivables Turnover Historical Data

* Premium members only.

The historical data trend for Labat Africa's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Labat Africa Receivables Turnover Chart

Labat Africa Annual Data
Trend Feb14 Feb15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 May23 May24
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.87 1.52 4.98 12.19 13.29

Labat Africa Semi-Annual Data
Aug15 Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Nov22 May23 Nov23 May24 Nov24 May25 Nov25
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.33 1.30 2.82 1.58 0.61

JSE:LAB vs ZTS, UTHR, VTRS: Receivables Turnover Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Labat Africa's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Labat Africa Receivables Turnover vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Labat Africa's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Labat Africa's Receivables Turnover falls into.



Labat Africa Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Labat Africa's Receivables Turnover for the fiscal year that ended in May. 2024 is calculated as

Receivables Turnover (A: May. 2024 )
=Revenue / Average Accounts Receivable
=Revenue (A: May. 2024 ) / ((Accounts Receivable (A: May. 2023 ) + Accounts Receivable (A: May. 2024 )) / count )
=48.536 / ((3.011 + 4.293) / 2 )
=48.536 / 3.652
=13.29

Labat Africa's Receivables Turnover for the quarter that ended in Nov. 2025 is calculated as

Receivables Turnover (Q: Nov. 2025 )
=Revenue / Average Accounts Receivable
=Revenue (Q: Nov. 2025 ) / ((Accounts Receivable (Q: May. 2025 ) + Accounts Receivable (Q: Nov. 2025 )) / count )
=150.884 / ((190.439 + 301.769) / 2 )
=150.884 / 246.104
=0.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Receivables Turnover →
What does a Receivables Turnover of 0.61 mean?
Labat Africa (JSE:LAB) has a Receivables Turnover of 0.61 as of Nov. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Labat Africa and its competitors. According to the industry distribution chart, Labat Africa ranks #872 out of 942 companies in the Drug Manufacturers industry, placing it in the top 92.6%.
Is Labat Africa's Receivables Turnover too high?
Labat Africa's current Receivables Turnover is 0.61. The Drug Manufacturers industry median Receivables Turnover is 5.07. Labat Africa's value of 0.61 is 88% below this industry median. Based on the distribution chart, Labat Africa ranks #872 out of 942 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Labat Africa's Receivables Turnover compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Labat Africa ranks #872 out of 942 companies for Receivables Turnover. This places Labat Africa in the lower half of its industry. The industry median Receivables Turnover is 5.07. Labat Africa's value of 0.61 is 88% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Drug Manufacturers company?
The median Receivables Turnover among Drug Manufacturers companies is 5.07, based on 942 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Labat Africa's current Receivables Turnover of 0.61 is 88% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Labat Africa and its competitors. For the Drug Manufacturers industry, the median Receivables Turnover is 5.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Labat Africa's current Receivables Turnover is 0.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labat Africa stock overvalued right now?
Based on GuruFocus' analysis, Labat Africa (JSE:LAB) is currently considered Possible Value Trap. The stock's GF Value™ is R0.22, compared to a current price of R0.05 — trading 77.3% below its estimated fair value. The current Receivables Turnover is 0.61 and 88% below the Drug Manufacturers industry median of 5.07. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Labat Africa (JSE:LAB), the current Receivables Turnover is 0.61 as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Labat Africa Business Description

Other Exchanges LAO:Germany
Address 75 Maude StreetSandown, The Leonardo 14th Floor, Sandown, Johannesburg, GT, ZAF, 1709
Labat Africa Ltd is an investment holding company. Through its subsidiaries, the company operates in the following segments; Technology, Head office, and Healthcare. The Technology segment manufactures and distributes integrated circuits South African Micro - Electronic Systems. Head office operations provide management services, logistics and seeks further investment opportunities for the Group. The Healthcare segment generates maximum revenue for the company and focusses on medical cannabis industry in South Africa. Geographically, the company carries out its business operations in South Africa.